東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Novel carrier systems for targeted a...

Yadav, Awesh K.

FindBook

Google Book

Amazon

博客來

Novel carrier systems for targeted and controlled drug delivery

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Novel carrier systems for targeted and controlled drug delivery/ edited by Awesh K. Yadav, Keerti Jain.
其他作者:	Yadav, Awesh K.
出版者:	Singapore :Springer Nature Singapore : : 2024.,
面頁冊數:	xv, 531 p. :ill., digital ;24 cm.
內容註:	Chapter 1_Fundamentals of targeted drug delivery -- Chapter 2_Influence of drug properties and routes of drug administration on design of sustained and controlled release systems -- Chapter 3_Polymeric materials in controlled drug delivery -- Chapter 4_Biopharmaceutic and pharmacokinetic aspects of peroral Controlled Drug Delivery Systems -- Chapter 5_Parenteral drug delivery -- Chapter 6_Proteins / peptides drug delivery systems -- Chapter 7_Transdermal / skin drug delivery system -- Chapter 8_Implantable Therapeutics Systems -- Chapter 9_Chemical drug delivery systems -- Chapter 10_Targeted brain delivery -- Chapter 11_Targeted Tumor Delivery -- Chapter 12_Miscellaneous targeting approaches: Fundamentals of gene delivery, Overview of colon, liver, macrophage, mitochondrial and M cells targeting -- Chapter 13_Overview of Specialized drug delivery systems: Transfersomes, Ethosomes, Layersomes, Bilosomes,Emulsomes, Virosomes, Cubosomes, Aquasomes, Pharmacosomes. Dendrimers, Polymeric Micelles and Resealed Erythrocytes -- Chapter 14_Controlled release formulations for alternate routes of administration -- Chapter 15_Stimuli responsive drug delivery systems: Magnetically, thermal and pH-assisted drug delivery systems -- Chapter 16_Role of controlled release in veterinary formulations -- Chapter 17_Colloidal drug delivery systems: (a) Liposomes and niosomes -- Chapter 18_Solid lipid nanoparticles and nanostructured lipid carriers -- Chapter 19_Polymeric nanoparticles - PLGA, chitosan, albumin, gelatin, alginate etc and Carbon nanotubes -- Chapter 20_Theranostics Application of Controlled Release Drug Delivery systems -- Chapter 21_Regulatory approval pathways involved in controlled release formulations.
Contained By:	Springer Nature eBook
標題:	Drug carriers (Pharmacy) -
電子資源:	https://doi.org/10.1007/978-981-97-4970-6
ISBN:	9789819749706

Novel carrier systems for targeted and controlled drug delivery
Novel carrier systems for targeted and controlled drug delivery[electronic resource] /edited by Awesh K. Yadav, Keerti Jain. - Singapore :Springer Nature Singapore :2024. - xv, 531 p. :ill., digital ;24 cm.

Chapter 1_Fundamentals of targeted drug delivery -- Chapter 2_Influence of drug properties and routes of drug administration on design of sustained and controlled release systems -- Chapter 3_Polymeric materials in controlled drug delivery -- Chapter 4_Biopharmaceutic and pharmacokinetic aspects of peroral Controlled Drug Delivery Systems -- Chapter 5_Parenteral drug delivery -- Chapter 6_Proteins / peptides drug delivery systems -- Chapter 7_Transdermal / skin drug delivery system -- Chapter 8_Implantable Therapeutics Systems -- Chapter 9_Chemical drug delivery systems -- Chapter 10_Targeted brain delivery -- Chapter 11_Targeted Tumor Delivery -- Chapter 12_Miscellaneous targeting approaches: Fundamentals of gene delivery, Overview of colon, liver, macrophage, mitochondrial and M cells targeting -- Chapter 13_Overview of Specialized drug delivery systems: Transfersomes, Ethosomes, Layersomes, Bilosomes,Emulsomes, Virosomes, Cubosomes, Aquasomes, Pharmacosomes. Dendrimers, Polymeric Micelles and Resealed Erythrocytes -- Chapter 14_Controlled release formulations for alternate routes of administration -- Chapter 15_Stimuli responsive drug delivery systems: Magnetically, thermal and pH-assisted drug delivery systems -- Chapter 16_Role of controlled release in veterinary formulations -- Chapter 17_Colloidal drug delivery systems: (a) Liposomes and niosomes -- Chapter 18_Solid lipid nanoparticles and nanostructured lipid carriers -- Chapter 19_Polymeric nanoparticles - PLGA, chitosan, albumin, gelatin, alginate etc and Carbon nanotubes -- Chapter 20_Theranostics Application of Controlled Release Drug Delivery systems -- Chapter 21_Regulatory approval pathways involved in controlled release formulations.

The book presents novel carrier systems for the targeted and controlled drug delivery for the treatment of various diseases which are difficult to be treated with conventional drug delivery systems like cancer, autoimmune disorders, and emerging infectious diseases. It also reviews the origins and applications of stimuli-responsive polymer systems and polymer therapeutics such as polymer-protein and polymer-drug conjugates. The book also explores the potential applications of the parenteral route of administration for the delivery of active pharmaceutical substances with a narrow therapeutic index and poor bioavailability. Further, the book presents common routes of administration for the systemic delivery of peptides and proteins. It also examines the applications of various implantable systems in drug delivery. The book also covers the important colloidal drug delivery systems, including liposomes and niosomes and solid lipid nanoparticles, and nanostructured lipid carriers. Towards,the end, the book discusses the therapeutic potential of biodegradable polymeric nanoparticles for controlled drug delivery. Authoritative and thorough, this book is a valuable resource for researchers working on a multidisciplinary approach to employing drug delivery systems.

ISBN: 9789819749706

Standard No.: 10.1007/978-981-97-4970-6doiSubjects--Topical Terms:

814579
Drug carriers (Pharmacy)

LC Class. No.: RS201.V43

Dewey Class. No.: 615.6

Novel carrier systems for targeted and controlled drug delivery
LDR:03994nmm a2200325 a 4500 001 2389242
003 DE-He213
005 20241224115238.0
006 m d
007 cr nn 008maaau
008 250916s2024 si s 0 eng d
020 $a 9789819749706 $q (electronic bk.)
020 $a 9789819749690 $q (paper)
024 7 $a 10.1007/978-981-97-4970-6 $2 doi
035 $a 978-981-97-4970-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RS201.V43
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615.6 $2 23
090 $a RS201.V43 $b N937 2024
245 0 0 $a Novel carrier systems for targeted and controlled drug delivery $h [electronic resource] / $c edited by Awesh K. Yadav, Keerti Jain.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2024.
300 $a xv, 531 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1_Fundamentals of targeted drug delivery -- Chapter 2_Influence of drug properties and routes of drug administration on design of sustained and controlled release systems -- Chapter 3_Polymeric materials in controlled drug delivery -- Chapter 4_Biopharmaceutic and pharmacokinetic aspects of peroral Controlled Drug Delivery Systems -- Chapter 5_Parenteral drug delivery -- Chapter 6_Proteins / peptides drug delivery systems -- Chapter 7_Transdermal / skin drug delivery system -- Chapter 8_Implantable Therapeutics Systems -- Chapter 9_Chemical drug delivery systems -- Chapter 10_Targeted brain delivery -- Chapter 11_Targeted Tumor Delivery -- Chapter 12_Miscellaneous targeting approaches: Fundamentals of gene delivery, Overview of colon, liver, macrophage, mitochondrial and M cells targeting -- Chapter 13_Overview of Specialized drug delivery systems: Transfersomes, Ethosomes, Layersomes, Bilosomes,Emulsomes, Virosomes, Cubosomes, Aquasomes, Pharmacosomes. Dendrimers, Polymeric Micelles and Resealed Erythrocytes -- Chapter 14_Controlled release formulations for alternate routes of administration -- Chapter 15_Stimuli responsive drug delivery systems: Magnetically, thermal and pH-assisted drug delivery systems -- Chapter 16_Role of controlled release in veterinary formulations -- Chapter 17_Colloidal drug delivery systems: (a) Liposomes and niosomes -- Chapter 18_Solid lipid nanoparticles and nanostructured lipid carriers -- Chapter 19_Polymeric nanoparticles - PLGA, chitosan, albumin, gelatin, alginate etc and Carbon nanotubes -- Chapter 20_Theranostics Application of Controlled Release Drug Delivery systems -- Chapter 21_Regulatory approval pathways involved in controlled release formulations.
520 $a The book presents novel carrier systems for the targeted and controlled drug delivery for the treatment of various diseases which are difficult to be treated with conventional drug delivery systems like cancer, autoimmune disorders, and emerging infectious diseases. It also reviews the origins and applications of stimuli-responsive polymer systems and polymer therapeutics such as polymer-protein and polymer-drug conjugates. The book also explores the potential applications of the parenteral route of administration for the delivery of active pharmaceutical substances with a narrow therapeutic index and poor bioavailability. Further, the book presents common routes of administration for the systemic delivery of peptides and proteins. It also examines the applications of various implantable systems in drug delivery. The book also covers the important colloidal drug delivery systems, including liposomes and niosomes and solid lipid nanoparticles, and nanostructured lipid carriers. Towards,the end, the book discusses the therapeutic potential of biodegradable polymeric nanoparticles for controlled drug delivery. Authoritative and thorough, this book is a valuable resource for researchers working on a multidisciplinary approach to employing drug delivery systems.
650 0 $a Drug carriers (Pharmacy) $3 814579
650 1 4 $a Pharmacology. $3 634543
650 2 4 $a Drug Delivery. $3 3531319
650 2 4 $a Diseases. $3 618693
700 1 $a Yadav, Awesh K. $3 3754837
700 1 $a Jain, Keerti. $3 3665444
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-97-4970-6
950 $a Medicine (SpringerNature-11650)